Page 5 - Wockhardt
Wockhardt ED Huzaifa Khorakiwala to raise Rs 125cr for health fund
Executive Director of Wockhardt Ltd Huzaifa Khorakiwala has launched a healthcare angel fund
Wockhardt gains as Daman unit gets GMP certificate from UK MHRA
The stock hit an intra-day high of Rs 723, with a combined 1.6 million shares exchanging hands on the counter on the BSE and NSE
 "Wockhardt gains as Daman unit gets GMP certificate from UK MHRA")
Wockhardt hits fresh 52-week low on warning letter to C P Pharma
The stock hit a fresh 52-week low of Rs 659, down 4.5% on BSE in early morning trade.
 "Wockhardt hits fresh 52-week low on warning letter to C P Pharma")
Nothing exciting about Wockhardt stock as yet
US sales continue to decline, pressuring profit and dampening the Street sentiment
Wockhardt hits 52-week low
The stock hit a 52-week low of Rs 683 in intra-day trade, down 16% in past seven trading sessions post Q2 results.
No critical observation by UK health regulator: Wockhardt
In December 2015, Wockhardt received a GMP certificate from the UK health regulator for its Chikalthana plant after an inspection
 "No critical observation by UK health regulator: Wockhardt")
Wockhardt surges on heavy volumes
The stock urged 14% to Rs 959 on the NSE on back of heavy volumes.
Wockhardt shares down nearly 4% as Q1 net profit dives
Wockhardt on Saturday reported a fall of 82.65 per cent in consolidated net profit to Rs 15.89 crore for the first quarter ended June 30
Expanding markets, launching new products for growth: Wockhardt
Company has always believed that R&D is the key to the future, said Wockhardt Chairman and group CEO Habil Khorakiwala
Wockhardt Q1 net profit dives 80% to Rs 16 cr
The India business of the company grew a marginal 10 per cent, despite launching 11 new products in the market
Wockhardt Q1 net profit dives 83% to Rs 16 crore
The company had posted a net profit after taxes at Rs 91.61 crore in the same period a year ago
Wockhardt tanks over 10% on import alert from US FDA for Ankleshwar plant
The stock tanked 14% to Rs 870 on the BSE in early morning trade.
Wockhardt gets import alert from US FDA
Ankleshwar plant is the third such facility to face action
Wockhardt gets US FDA report with 'observations'
The facilities are at Chikalthana and two units at Waluj in Maharashtra
Wockhardt dips on EIR with observations for three units
The stock dipped 5% to Rs 988, falling 12% from its early morning high of Rs 1,129 touched on the BSE,
Wockhardt approaches shareholders to raise up to Rs 1,200 crore
Company said it will utilise the money to re-pay or pre-pay term loan availed by it and for general corporate purposes
Wockhardt chief Habil Khorakiwala backs fast tracking of drug patents
New IPR policy unveiled last week aims to simplify and expedite patent application processes
 "Wockhardt chief Habil Khorakiwala backs fast tracking of drug patents")
Wockhardt net rises 26%
Cost control and tax adjustment help drug maker post better numbers despite 6% fall in overall revenue
Wockhardt gains on raising Rs 36cr from promoter group company
The company has raised Rs 36 crore from promoter group company Khorakiwala Holdings and Investments Pvt Ltd
 "Wockhardt gains on raising Rs 36cr from promoter group company")
